Authorized purpose: Diagnostic ultrasound; assisted abdominal FAST acquisition and anatomical labeling
Clinical role
Image acquisition support and anatomical labeling
Images and patients
Ultrasound · Abdomen; Heart/Cardiovascular; Obstetric/Gynecologic; Musculoskeletal; Lung; Small parts
Key limitation
Keep in mind: FAST Auto Assist is Android-only, adult-limited and available with S4-1/C5-2 transducers. Anatomical labels do not establish free-fluid diagnosis or replace clinician interpretation.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Diagnostic ultrasound; assisted abdominal FAST acquisition and anatomical labeling
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Abdomen; Heart/Cardiovascular; Obstetric/Gynecologic; Musculoskeletal; Lung; Small parts Input: Live ultrasound from compatible Lumify transducers; FAST Auto Assist uses S4-1 or C5-2 abdominal imaging
Who uses it?Intended users: Qualified healthcare professionals trained in ultrasound
What does the software produce?Output: Ultrasound images and FAST organ/zone labels for right upper quadrant, left upper quadrant and suprapubic views
What is its most important limitation?Key limitation: FAST Auto Assist is Android-only, adult-limited and available with S4-1/C5-2 transducers. Anatomical labels do not establish free-fluid diagnosis or replace clinician interpretation.
Clinical takeaway. Clinical role: Diagnostic ultrasound; assisted abdominal FAST acquisition and anatomical labeling
Evidence takeaway. Evidence from the reviewed source record: FDA review includes a retrospective FAST labeling evaluation of 82 emergency-department patients and 229 loops, plus a separate 20-patient clinical bench evaluation. These are anatomical-labeling studies, not evidence of improved trauma outcomes.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Diagnostic ultrasound; assisted abdominal FAST acquisition and anatomical labeling
FAST Auto Assist is Android-only, adult-limited and available with S4-1/C5-2 transducers. Anatomical labels do not establish free-fluid diagnosis or replace clinician interpretation.
FDA review includes a retrospective FAST labeling evaluation of 82 emergency-department patients and 229 loops, plus a separate 20-patient clinical bench evaluation. These are anatomical-labeling studies, not evidence of improved trauma outcomes.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA review includes a retrospective FAST labeling evaluation of 82 emergency-department patients and 229 loops, plus a separate 20-patient clinical bench evaluation. These are anatomical-labeling studies, not evidence of improved trauma outcomes.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Live ultrasound from compatible Lumify transducers; FAST Auto Assist uses S4-1 or C5-2 abdominal imaging
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The current Lumify app describes DICOM Store, Modality Performed Procedure Step and Storage Commitment support
Scope: Product family. Current family documentation does not establish the supported phone, OS or interface configuration for a purchased K252558 system.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: Compatible mobile device application with USB-connected transducer; system supports Android and iOS, but FAST Auto Assist is Android-only
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Unresolved route: Ultrasound images and FAST organ/zone labels for right upper quadrant, left upper quadrant and suprapubic views
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Philips' Responsible Disclosure Statement states that Philips maintains a global network of product security officers for developing and deploying security and privacy features for its products and services and for managing security events; that vulnerability reports to productsecurity@philips.com (PGP-encrypted) are acknowledged within two business days with a tracking number and an assigned contact; status updates approximately every 2-3 weeks; a 90-day resolution aim; and patch or advisory notification through existing customer notification processes. Vendor statement; no certification or test report was read.
Vendor-wide
Checked 2026-10-26
Vendor statement, not an attestation. Identity bridge: the statement is on philips.com (Royal Philips) and covers Philips products and services; the FDA applicant entity appears in Philips' own BCR members list on documents.philips.com (Philips Ultrasound LLC, Philips Medical Systems Nederland B.V., Philips Healthcare (Suzhou), Philips Medical Systems DMC GmbH, Philips Medical Systems Technologies Ltd., Philips Oy). Corporate policy; exact-release scope is not established.
Philips' coordinated vulnerability disclosure policy states a global product security officer network, PGP-based reporting, acknowledgement within 2 business days, report tracking, updates every 2-3 weeks, a 90-day resolution aim and customer notification.
Vendor-wide
Checked 2026-10-27
Vendor statement, not an attestation. The policy names Philips generally and does not scope these commitments to any specific product release; exact-release scope is not established.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Abdomen; Heart/Cardiovascular; Obstetric/Gynecologic; Musculoskeletal; Lung; Small parts
FDA source
Exact FDA submission
Checked 2026-09-05
System indications span multiple organs, including fetal/obstetric, abdominal, pediatric, cephalic, urologic, gynecologic, cardiac, vascular, musculoskeletal and lung imaging. FAST Auto Assist is abdominal only.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-05Last searched
15Fields reviewed
9Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads
NCT03486444 concerns next-generation ultrasound education and care; stored metadata screened, but exact FAST Auto Assist/version linkage was not established. Live registry page returned a JavaScript shell; no trial results promoted. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor product page, literature index, clinical trial registry, recall database, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-05 - Exact FDA submission
A regional Philips subscription page did not establish current US pricing or inclusion of this FAST feature, hardware and support.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Philips Lumify reimbursement guide CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. Philips' undated Lumify reimbursement guide describes general ultrasound claim structure; it names Lumify but not this clearance or any coverage, so it is kept as a lead. This records what was found, not that none exists.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-05 - Exact FDA submission
Required local onboarding, competency assessment and FAST-specific training package were not established.
Authorized purpose: Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric, musculoskeletal, ophthalmic, urologic, vascular, small-organ, and lung examinations.
Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Authorized purpose: WatchMate Software v1.2.0 processes transesophageal echocardiography data to reconstruct the left atrial appendage and assist preprocedural planning and device sizing during left-atrial-appendage closure.
Authorized purpose: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.